RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug
RedHill Gets Two New Patents for Crohn's Disease Candidate | Nasdaq
RedHill Bio gains 6% after Talicia shows efficacy in eradicating H. pylori infection | Seeking Alpha
RedHill Biopharma - Home
RedHill Biopharma - Home
RedHill Biopharma Ltd enters strategic agreement for the sale of its American Depositary Shares (ADSs) to South Korea's Kukbo Co. Ltd via an up to $10 million private placement
RedHill Biopharma Ltd. completes treatment and follow-up in the 475-patient global Phase 2/3 COVID-19 study with opaganib